Bluetongue virus cases have shot up in several European countries, data gathered by AFP on Tuesday (13 August) showed, as farmers are worrying about consequences for sheep and cattle.
The European Commission has initiated infringement procedures for Belgium, Spain, Croatia, Luxembourg, the Netherlands, and Sweden, asking them to comply with the EU's Digital Services Act (DSA), according to a Friday (26 July) press release.
Europe has vast differences in the stages of a medicine’s journey, from approval to pricing, and reimbursement, leading to significant delays and unequal patient access - often depending on a patient's residence.
The ongoing pharma package negotiations were marked by Belgium’s focus on combating medicine shortages and shaping the incentives system for new medicines development. Key issues remain in play for Hungary, including parallel imports.
After Ukraine and Moldova formally opened their accession talks on Tuesday (25 June), they are expected to kick off a process of further aligning their own legislation to the bloc, Euractiv spoke to both countries chief negotiators about their expectations for the next stages of the process.
A new wave of radioligand therapies is approaching. With healthcare systems and policymakers ill-equipped to handle the change, Belgium is launching an action plan.
Sanofi is emphasising the strategic importance of Belgium in its pharmaceutical research and development initiatives, while also highlighting the EU's potential to lead an artificial intelligence-driven revolution in medicine, particularly in medicines discovery.
Ursula von der Leyen may face complications in securing a second mandate, as her EU group, the EPP, is due to appear before a Brussels court next week, where the plaintiff in the case is seeking to have the EPP remove her as their top candidate for the Commission presidency.
Belgium's political landscape is undergoing a reshuffle, raising critical questions about how the new Belgian government will address the fragmented state of healthcare. Re-federalisation of the healthcare system is an idea gaining traction.
The future of Belgium’s pharmaceutical industry is under scrutiny as competition challenges Belgian success. Leading Belgian politicians discussed revamping pharma's road map in a recent conversation with Euractiv.
In its last stretch, the Belgian Presidency of the Council of the EU is discussing regulatory data protection (RDP) for medicinal products. The goal is to balance pharmaceutical innovation with timely patient access across the EU.
Belgium's far-right Flemish nationalist Vlaams Belang party vowed Sunday (2 June) to score a stunning victory in next weekend's elections and become the leading political force in the Dutch-speaking north.
Belgium and the Netherlands are pushing for a need-driven research model prioritising society's requirements, with an emphasis on addressing unmet medical needs, Belgium is viewed as setting the stage for future presidencies.
The pipeline of new antibiotics to curb the antimicrobial resistance crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives.
Ukraine's President Volodymyr Zelenskyy is expected to visit Brussels on Tuesday (28 May) to sign a security pact with Belgian Prime Minister Alexander De Croo. His visit to Belgium comes a day after the Ukrainian leader signed a similar bilateral security …
France's Sophie Adenot and Belgium's Raphael Liégeois will be the first two from a new class of European astronauts to blast off to the International Space Station, the European Space Agency said Wednesday (22 May).
Prioritising pollution prevention or human health? That's the question probing the ethical limits of Belgium's pharmaceutical industry, amidst discussion of whether to approve new medicines if environmental risk assessments prove inadequate.
The Belgian innovative pharmaceutical industry continues to grow, but competitiveness dynamics and EU pharma package revisions are causing uncertainty. Euractiv spoke in depth with Caroline Ven, CEO of pharma.be, about the sector's concerns.
While polling suggests far-right politicians in several European countries will do well in European Union elections next month, in the French-speaking part of Belgium they face a regional media boycott.
A Belgian court will hold a hearing on 17 May where it will be decided whether Belgian or EU prosecutors are competent to continue the 'Pfizergate' probe involving European Commission boss Ursula von der Leyen, according to a document seen by Euractiv.
Patients with rare diseases are clear beneficiaries of the European Parliament’s vote on the EU Pharma Package, says Belgian MEP Frédérique Ries. The revised package will also embed a European solidarity mechanism.
Belgium's federal prosecutor has launched an investigation against members of the European Parliament allegedly paid by Moscow, and Prime Minister Alexander De Croo will bring the issue of Russian interference to the top of next week's leaders' summit.
Despite its significant potential, Europe trails North America and the Asian Pacific in Advanced Therapy Medicinal Product development and investment. Belgium however, boasts one of the highest densities of advanced therapy companies globally.
Professor Peter Piot, Belgium’s special advisor to European Commission president Ursula von der Leyen on European and Global Health Security, has called antimicrobial resistance (AMR) a crisis already underway and gaining importance.
